Lifecore Biomedical Inc reports results for the quarter ended in November - Earnings Summary

Lifecore Biomedical

16/03/2023 21:48

* Lifecore Biomedical Inc  LFCR.OQ  reported a quarterly
adjusted
loss of 24 cents​​ per share for the quarter ended in November.
The mean expectation of three analysts for the quarter was for a
loss of 4 cents per share.
    * Revenue fell 42.6% to $24.95 million from a year ago;
analysts
expected $46.61 million. 
    * Lifecore Biomedical Inc's reported EPS for the quarter was
a
loss of 42 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lifecore Biomedical Inc shares had fallen by 22.7% this
quarter.
    * The company reported a quarterly loss of $12.45 million.
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $13.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 09:48 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Nov. 30 2022      -0.04          -0.24          Missed
 Aug. 31 2022      -0.13          -0.32          Missed
 May. 31 2022      -0.01          -0.01          Met
 Feb. 28 2022      0.00           -0.08          Missed